Therapy Areas: Central Nervous System
14 September 2017 - - Baltimore, Maryland-based neurodegeneration therapies developer AgeneBio has been awarded a grant for up to USD 10m from the National Institute on Aging of the Nat...
14 September 2017 - - Baltimore, Maryland-based neurodegeneration therapies developer AgeneBio has been awarded a grant for up to USD 10m from the National Institute on Aging of the Nat...
6 September 2017 - - Palo Alto, California-based rare disease therapeutics developer Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) has been granted orphan drug designation by the US Food and Drug Admi...
6 September 2017 - Medical imaging company Guerbet LLC USA reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for Dotarem for intravenous use with magnetic reso...
6 September 2017 - Switzerland-based Novartis' multiple sclerosis drug Gilenya (fingolimod) has shown significant effect in a phase III Paradigms study, it was announced yesterday.The company has...
5 September 2017 - Japanese multinational Takeda Pharmaceutical has set its scope on the global market after the company's CEO publicised its new strategy in an interview with CNBC on Tuesday.Tak...